monsitj Novavax ( NASDAQ: NVAX ) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting with management. Jefferies said Novavax was ramping up Covid-19 vaccine U.S.
sales and was on track to meet revenue guidance for the ‘24/’25 season.
